Stimulating hypocretin receptors improves sleepiness and vigilance in idiopathic hypersomnia: lessons from a proof of concept study.
作者信息
Arnulf Isabelle, Maranci Jean-Baptiste
机构信息
National Reference Center for Narcolepsy and Rare Hypersomnias, Sleep Clinic, Pitie-Salpetriere Hospital, APHP-Sorbonne University, Paris, France.
出版信息
Sleep. 2023 Sep 8;46(9). doi: 10.1093/sleep/zsad085.
Abstract
摘要
相似文献
1
Stimulating hypocretin receptors improves sleepiness and vigilance in idiopathic hypersomnia: lessons from a proof of concept study.
Sleep. 2023 Sep 8;46(9). doi: 10.1093/sleep/zsad085.
2
Narcolepsy and Idiopathic Hypersomnia.
Sleep Med Clin. 2023 Jun;18(2):183-199. doi: 10.1016/j.jsmc.2023.01.003. Epub 2023 Mar 8.
3
Pharmacologic Management of Excessive Daytime Sleepiness.
Sleep Med Clin. 2020 Jun;15(2):177-194. doi: 10.1016/j.jsmc.2020.02.006.
4
Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia.
Sleep. 2023 Sep 8;46(9). doi: 10.1093/sleep/zsad049.
5
Idiopathic Hypersomnia and Depression, the Challenge for Clinicians and Researchers.
Prague Med Rep. 2021;122(3):127-139. doi: 10.14712/23362936.2021.13.
6
Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion.
Sleep Med Rev. 2023 Jun;69:101766. doi: 10.1016/j.smrv.2023.101766. Epub 2023 Feb 25.
7
Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
Expert Opin Drug Discov. 2022 Feb;17(2):109-119. doi: 10.1080/17460441.2022.1999226. Epub 2021 Nov 24.
8
Face validation and pharmacologic analysis of Sik3 mutant mouse as a possible model of idiopathic hypersomnia.
Eur J Pharmacol. 2023 Sep 5;954:175877. doi: 10.1016/j.ejphar.2023.175877. Epub 2023 Jun 24.
9
Evaluation of pathological sleepiness by Multiple Sleep Latency Test and 24-hour polysomnography in patients suspected of idiopathic hypersomnia.
Psychiatry Clin Neurosci. 2021 Apr;75(4):149-151. doi: 10.1111/pcn.13196. Epub 2021 Feb 13.
10
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
Lancet Neurol. 2022 Jan;21(1):53-65. doi: 10.1016/S1474-4422(21)00368-9.
本文引用的文献
1
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals.
J Sleep Res. 2023 Oct;32(5):e13878. doi: 10.1111/jsr.13878. Epub 2023 Mar 19.
2
Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion.
Sleep Med Rev. 2023 Jun;69:101766. doi: 10.1016/j.smrv.2023.101766. Epub 2023 Feb 25.
3
Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia.
Sleep. 2023 Sep 8;46(9). doi: 10.1093/sleep/zsad049.
4
Clinical considerations for the diagnosis of idiopathic hypersomnia.
Sleep Med Rev. 2022 Dec;66:101709. doi: 10.1016/j.smrv.2022.101709. Epub 2022 Oct 31.
5
Precision Medicine for Idiopathic Hypersomnia.
Sleep Med Clin. 2022 Sep;17(3):379-398. doi: 10.1016/j.jsmc.2022.06.016. Epub 2022 Sep 8.
6
Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2207531119. doi: 10.1073/pnas.2207531119. Epub 2022 Aug 22.
7
Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.
Neurology. 2022 Jun 7;98(23):e2387-e2400. doi: 10.1212/WNL.0000000000200519. Epub 2022 Apr 18.
8
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
Lancet Neurol. 2022 Jan;21(1):53-65. doi: 10.1016/S1474-4422(21)00368-9.
9
Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study.
Sleep Med. 2021 Apr;80:315-321. doi: 10.1016/j.sleep.2021.01.018. Epub 2021 Jan 20.
10
To split or to lump? Classifying the central disorders of hypersomnolence.
Sleep. 2020 Aug 12;43(8). doi: 10.1093/sleep/zsaa044.
Zotero 插件